These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34590547)

  • 1. Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and
    Kandilli B; Ugur Kaplan AB; Cetin M; Taspınar N; Genc S; Yeni Y; Ertugrul MS; Aydin IC; Hacimuftuoglu A
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1153-1165. PubMed ID: 34590547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method:
    Kandilli B; Ugur Kaplan AB; Cetin M; Taspinar N; Ertugrul MS; Aydin IC; Hacimuftuoglu A
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1063-1072. PubMed ID: 32406290
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
    Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
    Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients.
    Conceição J; Adeoye O; Cabral-Marques H; Concheiro A; Alvarez-Lorenzo C; Sousa Lobo JM
    AAPS PharmSciTech; 2020 Jan; 21(2):39. PubMed ID: 31897724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
    Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM
    Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
    Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
    Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet.
    Aslani A; Beigi M
    Int J Prev Med; 2016; 7():120. PubMed ID: 27857833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
    Kanemura H; Sano F; Ohyama T; Aihara M
    Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impairment of motor coordination following chronic carbamazepine-levetiracetam combination treatment with evidence of corticocerebellar toxicity in male Wistar rats.
    Samson Osuntokun O; Grace Akingboye B; Olayiwola G; Adekemi Abayomi T; Oladele Ayoka A
    Brain Res; 2021 Sep; 1767():147565. PubMed ID: 34175264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
    Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
    Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
    Yamashita H; Sun CC
    Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats.
    Osuntokun OS; Babatunde AA; Olayiwola G; Atere TG; Oladokun OO; Adedokun KI
    Toxicol Rep; 2021; 8():592-598. PubMed ID: 33786324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: Inhibition of cholinergic transmission.
    Osuntokun OS; Abdulwahab UF; Akanji NO; Adedokun KI; Adekomi AD; Olayiwola G
    Neurosci Lett; 2021 Sep; 762():136167. PubMed ID: 34389480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2010 May; 18(1-2):74-80. PubMed ID: 20462801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.